Adjuvant and neoadjuvant treatment of breast cancer

被引：25

作者：

Gianni, L ^{[1
]}

Valagussa, P ^{[1
]}

Zambetti, M ^{[1
]}

Moliterni, A ^{[1
]}

Capri, G ^{[1
]}

Bonadonna, G ^{[1
]}

机构：

[1] Ist Nazl Tumori, I-20133 Milan, Italy

来源：

SEMINARS IN ONCOLOGY | 2001年 / 28卷 / 01期

关键词：

D O I：

10.1053/sonc.2001.20747

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：13 / 29

页数：17

共 60 条

[21] DIMITROV N, 1994, P AN M AM SOC CLIN, V13, P64
[22] 2 MONTHS OF DOXORUBICIN-CYCLOPHOSPHAMIDE WITH AND WITHOUT INTERVAL REINDUCTION THERAPY COMPARED WITH 6 MONTHS OF CYCLOPHOSPHAMIDE, METHOTREXATE, AND FLUOROURACIL IN POSITIVE-NODE BREAST-CANCER PATIENTS WITH TAMOXIFEN-NONRESPONSIVE TUMORS - RESULTS FROM THE NATIONAL SURGICAL ADJUVANT BREAST AND BOWEL PROJECT B-15
FISHER, B
BROWN, AM
DIMITROV, NV
POISSON, R
REDMOND, C
MARGOLESE, RG
BOWMAN, D
WOLMARK, N
WICKERHAM, DL
KARDINAL, CG
SHIBATA, H
PATERSON, AHG
SUTHERLAND, CM
ROBERT, NJ
AGER, PJ
LEVY, L
WOLTER, J
WOZNIAK, T
FISHER, ER
DEUTSCH, M
[J]. JOURNAL OF CLINICAL ONCOLOGY, 1990, 8 (09) : 1483 - 1496
[23] Tamoxifen and chemotherapy for lymph node-negative, estrogen receptor-positive breast cancer
Fisher, B
Dignam, J
Wolmark, N
DeCillis, A
Emir, B
Wickerham, DL
Bryant, J
Dimitrov, NV
Abramson, N
Atkins, JN
Shibata, H
Deschenes, L
Margolese, RG
[J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1997, 89 (22): : 1673 - 1682
[24] Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: Findings from National Surgical Adjuvant Breast and Bowel Project B-18
Fisher, B
Brown, A
Mamounas, E
Wieand, S
Robidoux, A
Margolese, RG
Cruz, AB
Fisher, ER
Wickerham, DL
Wolmark, N
DeCillis, A
Hoehn, JL
Lees, AW
Dimitrov, NV
[J]. JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (07) : 2483 - 2493
[25] FISHER B, 1983, CANCER RES, V43, P1488
[26] Effect of preoperative chemotherapy on the outcome of women with operable breast cancer
Fisher, B
Bryant, J
Wolmark, N
Mamounas, E
Brown, A
Fisher, ER
Wickerham, DL
Begovic, M
DeCillis, A
Robidoux, A
Margolese, RG
Cruz, AB
Hoehn, JL
Lees, AW
Dimitrov, NV
Bear, HD
[J]. JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (08) : 2672 - 2685
[27] Fisher B, 1996, SEMIN ONCOL, V23, P414
[28] 1-PHENYLALANINE MUSTARD (L-PAM) IN MANAGEMENT OF PRIMARY BREAST-CANCER - REPORT OF EARLY FINDINGS
FISHER, B
CARBONE, P
ECONOMOU, SG
FRELICK, R
GLASS, A
LERNER, H
REDMOND, C
ZELEN, M
BAND, P
KATRYCH, DL
WOLMARK, N
FISHER, ER
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1975, 292 (03) : 117 - 122
[29] Efficacy, toxicity, and applicability of high-dose sequential chemotherapy as adjuvant treatment in operable breast cancer with 10 or more involved axillary nodes: Five-year results
Gianni, AM
Siena, S
Bregni, M
DiNicola, M
Orefice, S
Cusumano, F
Salvadori, B
Luini, A
Greco, M
Zucali, R
Rilke, F
Zambetti, M
Valagussa, P
Bonadonna, G
[J]. JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (06) : 2312 - 2321
[30] RECOMBINANT HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR REDUCES HEMATOLOGIC TOXICITY AND WIDENS CLINICAL APPLICABILITY OF HIGH-DOSE CYCLOPHOSPHAMIDE TREATMENT IN BREAST-CANCER AND NON-HODGKINS-LYMPHOMA
GIANNI, AM
BREGNI, M
SIENA, S
ORAZI, A
STERN, AC
GANDOLA, L
BONADONNA, G
[J]. JOURNAL OF CLINICAL ONCOLOGY, 1990, 8 (05) : 768 - 778

← 1 2 3 4 5 6 →